A service of StreetInsider.com
Welcome

Most Popular

AAPL 197.03
C 3.20
GOOG 540.91
BAC 14.67
RIMM 66.89

Recently Added

IDC 29.07
WCH 0.15
SEWE 0.90
DGRI 0.15
CTGI 0.13

Gaining Speed

MKSI 18.58
CTGI 0.13
HLXW 1.58
ISL 14.62
DYP 8.48
1.77 +0.04 (2.33%) NBS

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:1.77 Change:+0.04 (2.33%) Prev Close:1.73 Open: 1.72 Days Range:1.72 – 1.93 52 Week Range: 0.45 - 2.72 Volume:21606 P/E: N/A
EPS:-2.07

Member Comments

No member comments available for NBS


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 02/09/10

Recent Alert on 02/01/10 at 8:48am
NeoStem (NBS) Chinese Subsidiary Receives OK from China SFDA to Manufacture Penicilin

NeoStem, Inc. (AMEX: NBS) announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile... Read More

Recent Alert on 01/25/10 at 1:13pm
Unusual 11 Mid-Day Movers 1/25: SMTX, NBS, KFS, SILC, PVTB Higher; PARD, ZAGG, DEAR, BBX Lower
Recent Alert on 01/25/10 at 10:54am
Morning Movers 1/25: SMTX, NBS, ERI, KFS, PVTB, CADC Higher; PARD, SNEN, BBX, PCBC Lower
Recent Alert on 12/07/09 at 9:50am
NeoStem (NBS) Announces Stem Cell Abstract Chosen for ASH Presentation

View AllRecent Press Releases

Press Release on 02/09/10 at 8:00am
Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network
Press Release on 02/09/10 at 8:00am
Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 02/09/10 at 10:10am
Some Small-Cap Biotech Stocks Worth Watching
Blog Posts on 02/08/10 at 10:36am
China Biotech Week in Review: New Investments in Life Science
Blog Posts on 02/03/10 at 8:02am
NeoStem Taps Chinese Healthcare Reform Profits
Blog Posts on 02/02/10 at 5:50am
NeoStem's Eyre Subsidiary Approved to Use New Manufacturing Facility
Blog Posts on 01/31/10 at 10:11am
China Biotech in Review: More Money Raised in China IPOs in 2009 than in the U.S.